CYTR - .44 Pre-market now at .57/.5807 CytRx Announces FDA Agreement on Regulatory Pathway to Approval for Aldoxorubicin in Soft Tissue Sarcomas http://stockcharts.com/c-sc/sc?s=CYTR&p=D&b=5&g=0&i=t50275487729&r=1492602607258 http://stockcharts.com/c-sc/sc?s=CYTR&p=W&b=5&g=0&i=t77960570753&r=1492602587070